MEDICINAL TREATMENT OPTIMISATION OF RESIDENTS OF ESTABLISHMENTS FOR ELDERLY DEPENDENT PERSONS: FIRST RESULTS OF A PROGRAMME IMPLEMENTED IN A GERONTOLOGICAL SECTOR
INT-015
SIDE-EFFECTS AND TREATMENT RESPONSE TO METHOTREXATE ASSOCIATED WITH COMORBIDITY IN EARLY RHEUMATOID ARTHRITIS
INT-013
DEVELOPING A MANIPULATION GUIDELINE FOR SOLID ORAL DOSAGE FORMS TO EASE SWALLOWING
INT-012
THE START OF PAEDFORM – A PAN-EUROPEAN PAEDIATRIC FORMULARY
INT-008
IMPLEMENTATION OF PHARMACEUTICAL CONSULTATION IN PRIMARY HEALTH CARE – PHARMACOTHERAPY FOLLOW-UP OF POLYMEDICATED ELDERLY PATIENTS IN ULSCB HEALTH CENTRE, EPE
INT-011
PREVALENCE AND PHARMACOTHERAPEUTIC COMPLEXITY OF POLYPHARMACY IN HIV+ PATIENTS IN SPAIN: POINT STUDY
INT-002
STANDARDISATION OF MEDICATION COUNSELLING MATERIAL FOR PAEDIATRIC SOLID ORGAN TRANSPLANT RECIPIENTS AND THEIR FAMILIES
INT-009
DEVELOPMENT AND IMPLEMENTATION OF ‘CHECK OF MEDICATION APPROPRIATENESS’ IN A LARGE TERTIARY CARE CENTRE
INT-005
MORPHINE HYDROCHLORIDE SOLUTION 0.5 MG/ML: A RECONSTITUTION KIT FOR NEONATAL UNITS
INT-004
PHYSICOCHAEMICAL STABILITY OF CARFILZOMIB (KYPROLIS®) CONTAINING SOLUTIONS AFTER RECONSTITUTION AND READY-TO-ADMINISTER PREPARATIONS
INT-008
EFFICACY OF HYDROXYCHLOROQUINE IN PRIMARY HAND OSTEOARTHRITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL
INT-012
PHARMACY BASED DOSING OF DARBEPOETIN: A RANDOMIZED CONTROLLED TRIAL IN HEMODIALYSIS PATIENTS
INT-011
ADR AND INTERACTIONS OF NEW DIRECT ANTIVIRAL AGENTS FOR HEPATITIS C TREATMENT
INT-010
IMPACT OF DRUGS ON HYPOGLYCEMIA IN HOSPITALIZED PATIENTS
INT-007
ADMINISTRATION OF SOLID DOSAGE FORMS TO PATIENTS WITH DYSPHAGIA OR VIA FEEDING TUBES
